The biotechnology industry began in the 1970s based, for the most part, on new recombinant DNA practices, and is now one of the most highly researched industries in the world. Biotechnology is a $30 billion a year industry – $19.8 billion was spent by the U.S. biotechnology industry in 2005. From this research, more than 160 drugs and vaccines were created, and over 370 biotech drugs and vaccines are currently in clinical trials targeting health issues such as cancer, Alzheimer’s, heart disease, AIDS, and arthritis. In the U.S., there are 1,473 biotechnology companies, 314 which are publicly held.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
TALECRIS BIOTHERAPEUTICS HOLDINGS CORP.
ENDO PHARMACEUTICALS HOLDINGS INC.
INVERNESS MEDICAL INNOVATIONS, INC.
MILLENNIUM PHARMACEUTICALS, INC.
MARTEK BIOSCIENCES CORPORATION
UNITED THERAPEUTICS CORPORATION
VERTEX PHARMACEUTICALS INCORPORATED
ALBANY MOLECULAR RESEARCH, INC.
CARACO PHARMACEUTICAL LABORATORIES, LTD.
AUXILIUM PHARMACEUTICALS, INC.
"Cortera has the potential to reinvent the credit reporting industry by bringing the credit community approach to the Web and thus delivering the kind of insight not possible with traditional credit bureau approaches alone."
"Cortera allows us to manage our global account base on one platform, and frees us from the inconsistencies inherent in managing credit in a decentralized, paper-based environment."
